美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA205268"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
68462-408-60 68462-408 HUMAN PRESCRIPTION DRUG propafenone hydrochloride propafenone hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20170908 N/A ANDA ANDA205268 Glenmark Pharmaceuticals Inc., USA PROPAFENONE HYDROCHLORIDE 225 mg/1 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-408-60)
68462-409-60 68462-409 HUMAN PRESCRIPTION DRUG propafenone hydrochloride propafenone hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20170908 N/A ANDA ANDA205268 Glenmark Pharmaceuticals Inc., USA PROPAFENONE HYDROCHLORIDE 325 mg/1 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-409-60)
68462-410-60 68462-410 HUMAN PRESCRIPTION DRUG propafenone hydrochloride propafenone hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20170908 N/A ANDA ANDA205268 Glenmark Pharmaceuticals Inc., USA PROPAFENONE HYDROCHLORIDE 425 mg/1 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-410-60)
16714-825-01 16714-825 HUMAN PRESCRIPTION DRUG propafenone hydrochloride propafenone hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20180716 N/A ANDA ANDA205268 Northstar Rx LLC PROPAFENONE HYDROCHLORIDE 225 mg/1 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16714-825-01)
16714-826-01 16714-826 HUMAN PRESCRIPTION DRUG propafenone hydrochloride propafenone hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20180716 N/A ANDA ANDA205268 Northstar Rx LLC PROPAFENONE HYDROCHLORIDE 325 mg/1 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16714-826-01)
16714-827-01 16714-827 HUMAN PRESCRIPTION DRUG propafenone hydrochloride propafenone hydrochloride CAPSULE, EXTENDED RELEASE ORAL 20180716 N/A ANDA ANDA205268 Northstar Rx LLC PROPAFENONE HYDROCHLORIDE 425 mg/1 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16714-827-01)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase